• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶“维琴察”的纯化:一种具有正常肝素亲和力但对凝血酶反应性受损的分子。

Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.

作者信息

Finazzi G, Tran T H, Barbui T, Duckert F

出版信息

Br J Haematol. 1985 Feb;59(2):259-63. doi: 10.1111/j.1365-2141.1985.tb02992.x.

DOI:10.1111/j.1365-2141.1985.tb02992.x
PMID:3970857
Abstract

Antithrombin III (AT) 'Vicenza', a previously described dysfunctional AT associated with familial thrombosis, has been isolated by heparin affinity chromatography. The purified molecule has been investigated by SDS-polyacrylamide gel electrophoresis and crossed immunoelectrophoresis after incubation with different amounts of thrombin. A normal affinity for heparin has been demonstrated. However, evidence is produced that AT 'Vicenza' poorly inhibits thrombin. Present data suggest that AT 'Vicenza' consists of a population of two molecules, half of which does not form a complex with thrombin however and loses its heparin affinity upon thrombin treatment.

摘要

抗凝血酶III(AT)“维琴察”是一种先前描述的与家族性血栓形成相关的功能失调的AT,已通过肝素亲和层析法分离出来。纯化后的分子经十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-聚丙烯酰胺凝胶电泳)和与不同量凝血酶孵育后的交叉免疫电泳分析。已证实其对肝素有正常亲和力。然而,有证据表明AT“维琴察”对凝血酶的抑制作用较弱。目前的数据表明,AT“维琴察”由两种分子组成,其中一半分子不能与凝血酶形成复合物,并且在凝血酶处理后失去其肝素亲和力。

相似文献

1
Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.抗凝血酶“维琴察”的纯化:一种具有正常肝素亲和力但对凝血酶反应性受损的分子。
Br J Haematol. 1985 Feb;59(2):259-63. doi: 10.1111/j.1365-2141.1985.tb02992.x.
2
Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza').遗传性抗凝血酶III功能障碍新变异型(抗凝血酶III“维琴察”)中凝血酶诱导异常的免疫电泳证据。
Br J Haematol. 1983 Aug;54(4):561-5. doi: 10.1111/j.1365-2141.1983.tb02134.x.
3
Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza').功能异常抗凝血酶新变体(抗凝血酶“维琴察”)与凝血酶的异常反应性
Ric Clin Lab. 1984 Jul-Sep;14(3):515-9. doi: 10.1007/BF02904879.
4
Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.凝血酶结合受损的遗传性异常抗凝血酶III的纯化与特性分析
J Lab Clin Med. 1984 Aug;104(2):245-56.
5
Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
Br J Haematol. 1987 Apr;65(4):451-6. doi: 10.1111/j.1365-2141.1987.tb04149.x.
6
Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.抗凝血酶III米兰变异体的纯化及进一步特性研究:与凝血酶无反应性
Thromb Haemost. 1987 Oct 28;58(3):888-92.
7
Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.两种病理性抗凝血酶III分子的鉴别:抗凝血酶III“Aalborg”和抗凝血酶III“Budapest”
Thromb Res. 1982 May 1;26(3):211-9. doi: 10.1016/0049-3848(82)90142-6.
8
Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.抗凝血酶维琴察,丙氨酸384突变为脯氨酸(GCA变为CCA),使抑制剂转变为底物。
Br J Haematol. 1991 Jan;77(1):87-92. doi: 10.1111/j.1365-2141.1991.tb07953.x.
9
Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").具有缺陷性丝氨酸蛋白酶结合能力的异常抗凝血酶III(抗凝血酶III“丹佛型”)
J Clin Invest. 1986 Mar;77(3):887-93. doi: 10.1172/JCI112386.
10
Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.抗凝血酶格拉斯哥II型:丝氨酸蛋白酶抑制剂P12位的丙氨酸382突变为苏氨酸,导致与凝血酶发生底物反应。
Br J Haematol. 1991 Sep;79(1):70-4. doi: 10.1111/j.1365-2141.1991.tb08009.x.